IMNM News

A total of 29 companies entered the public market this past week, the most ever in a single week. The week’s 11 IPOs were joined by 15 SPACs and three direct listings. Notable new IPO filings included TPG-backed antivirus provider McAfee (MCFE), Vista Equity’s IT software provider Datto (MSP), and three mortgage companies. ...read more

Immunome, a preclinical biotech developing antibody therapies for cancer and infectious diseases, raised $39 million by offering 3.3 million shares at $12, within the range of $11 to $13. The company offered 0.8 million more shares than anticipated. At pricing, the company raised 30% more in proceeds than expected. Immunome plans to list on the Nasdaq under the symbol IMNM....read more

Updated Monday, 9/28. 11 IPOs and two direct listings are scheduled to go public in the week ahead. The diverse group includes three foreign tech issuers, two biotechs, two US tech unicorns, a sporting goods retailer, an avocado supplier, a medical device maker, and a foreign education company. More SPACs will likely join the calendar as well. ...read more

Immunome, a preclinical biotech developing antibody therapies for cancer and infectious diseases, announced terms for its IPO on Thursday. The Exton, PA-based company plans to raise $30 million by offering 2.5 million shares at a price range of $11 to $13. Insiders intend to buy $20 million worth of shares in the offering. At the midpoint of the proposed range, Immunome would...read more